GE HealthCare Technologies Inc.·4

May 11, 8:08 PM ET

Madden Anne T 4

Research Summary

AI-generated summary

Updated

GE HealthCare (GEHC) Director Anne T. Madden Receives Stock Award

What Happened

  • Anne T. Madden, a director of GE HealthCare Technologies Inc. (GEHC), was granted two equity awards on May 7, 2026: 3,586 restricted stock units (RSUs) and 2,282 deferred stock units. Both awards were reported as acquired at $0.00 (award/grant, transaction code A). Total units awarded = 5,868; no cash changed hands for the awards themselves.

Key Details

  • Transaction date: May 7, 2026. Filing date: May 11, 2026 (filed four days after the transaction).
  • Reported price: $0.00 per unit (award/grant).
  • Shares owned after transaction: not disclosed in this filing.
  • Footnotes:
    • F1: 3,586 RSUs vest 100% on the earlier of GE HealthCare's next annual meeting or May 7, 2027; settlement may be deferred per the director's election under the Non-Employee Director Compensation and Benefits Plan.
    • F2: Each RSU and deferred stock unit represents the right to receive one share of GE HealthCare common stock at settlement.
    • F3: 2,282 are fully vested deferred stock units awarded in lieu of 100% of the director's cash retainer; settlement will follow the reporting person's deferral election.
  • Timeliness: The Form 4 was filed May 11 for a May 7 transaction, which is later than the typical two-business-day filing requirement for insiders (the filing appears late).

Context

  • These entries are awards/compensation for a non-employee director, not open-market purchases or sales. RSUs and deferred stock units are common components of director pay and convert to shares only upon vesting/settlement. Such grants are routine compensation and do not by themselves indicate the director buying or selling stock in the market.